May 13, 2024 Post navigation PDS Biotech VERSATILE-002 Phase 2 Clinical Trial Meets Primary Study Endpoints in First Line Recurrent/Metastatic HPV16-Positive Head and Neck CancerNetScientific takes charge of £23.3m Martlet Capital portfolio and acquires operational business